You're reading the free version. Trader adds the live tape and alerts.
Start tracking
AKTX Exercise Disclosure
Patel Sandip I · SEC Form 4 · Filed Oct 16, 2026
Exercise
Calculated transaction value
$62.47K
Patel Sandip I Director
AKTX
Transaction date
Oct 14, 2026
Public filing date
Oct 16, 2026
Filing lag
Filed 2 days later
AKTX daily price context
No linked price history
This asset is not matched to a market-data symbol.
Source details
- Reported owner
- Not disclosed
- Source asset code
- Derivative
- Security
- Pre-Funded Warrant to Purchase ADSs on American Depositary Shares representing Ordinary Shares
- Quantity / price
- 3,866 shares @ $16.16
- SEC ownership
- Direct
- Transaction code
- M
- Form
- 4
- Filing identifier
- 0001493152-26-047456
Filing cohort
Transactions in this filing
Showing 8 of 8
Trades
8
Issuers
1
Estimated value
$292.09K
Buys / sales
0 / 0
| Issuer | Transaction | Traded | Value |
|---|---|---|---|
| Akari Therapeutics Plc AKTX | Exercise | Oct 14, 2026 | $1.55 |
| Akari Therapeutics Plc AKTX | Exercise | Oct 14, 2026 | $2.47 |
| Akari Therapeutics Plc AKTX Current | Exercise | Oct 14, 2026 | $62.47K |
| Akari Therapeutics Plc AKTX | Exercise | Oct 14, 2026 | $99.97K |
| Akari Therapeutics Plc AKTX | Award | Oct 5, 2026 | $34.07K |
| Akari Therapeutics Plc AKTX | Award | Aug 18, 2026 | $0 |
| Akari Therapeutics Plc AKTX | Award | Aug 18, 2026 | $95.58K |
| Akari Therapeutics Plc AKTX | Award | Aug 18, 2026 | $0 |